How Long Does Vyvanse Stay in Your System: Half-Life & Tests

Vyvanse (lisdexamfetamine) stays in your system for roughly two to three days after a single therapeutic dose, depending on what “in your system” means to the test being used. The drug itself disappears from your blood within about an hour, but the d-amphetamine it releases has a half-life of around 10 hours, and that metabolite is what drug tests actually detect. The story gets more complicated when you factor in urine pH, kidney function, and which type of test you’re facing.

Why Vyvanse Has Two Half-Lives

Vyvanse is not amphetamine. It is a prodrug, meaning it is pharmacologically inactive until your body converts it. When you swallow a Vyvanse capsule, the lisdexamfetamine molecule travels to your red blood cells, where an enzyme clips off the amino acid lysine and frees d-amphetamine, the compound that actually treats ADHD symptoms.

This conversion step is the reason Vyvanse has two distinct half-lives. The intact lisdexamfetamine molecule clears your blood fast, with a half-life of roughly half an hour.

¹ That number is almost irrelevant to your daily experience with the medication, because the lisdexamfetamine shell is just a delivery vehicle. The d-amphetamine it releases is what produces effects and what lingers.

D-amphetamine’s half-life, by contrast, averages about 10 hours in healthy adults, though published studies report a range from roughly 9 to 15 hours depending on the population studied.

² In practical terms, if you take a dose in the morning and d-amphetamine peaks in your blood around three hours later, about half of that peak concentration remains by early evening. After another 10 hours, a quarter remains. After about five half-lives, the drug is considered functionally eliminated from your bloodstream, which puts you at roughly two to two-and-a-half days for most people.

Detection Windows by Test Type

The window during which Vyvanse can be detected depends heavily on the specimen collected. A clinical study that gave healthy volunteers a single therapeutic dose of lisdexamfetamine and then tested both urine and oral fluid found that the two matrices have similar but not identical detection windows.

Urine

Amphetamine was detectable in urine for a median of about 77 hours after a single dose of lisdexamfetamine, which works out to a little over three days.

³ Urine is the most common specimen in workplace and clinical drug testing, and standard immunoassay screens use a cutoff of 500 or 1,000 nanograms per milliliter for amphetamines. If you’re taking Vyvanse as prescribed, your urine will almost certainly trigger a positive result on a standard panel for the first couple of days after your last dose, and possibly into a third day. People who take Vyvanse daily rather than as a single dose will accumulate more d-amphetamine, which can push the detection window somewhat further.

Oral Fluid (Saliva)

Saliva testing detected amphetamine for a median of about 67 hours after a single lisdexamfetamine dose, roughly two and a half to three days.

³ Oral fluid tests are increasingly popular in roadside and workplace settings because they are harder to tamper with. The detection window is slightly shorter than urine but in the same ballpark, so the practical difference between the two is small for a single-dose scenario.

Hair

Hair testing operates on a completely different timescale. Rather than catching recent use, a standard hair test covers roughly the past 90 days by analyzing the 1.5-inch segment of hair closest to the scalp. A study of ADHD patients taking lisdexamfetamine found that d-amphetamine was detectable in all hair samples tested.

⁴ Hair testing can confirm that someone used the drug within the window covered by the segment analyzed, but interindividual variability in how much drug ends up in hair means it cannot reliably gauge dose or frequency.

Blood

Blood (or plasma) testing is the least common in routine screening but the most precise for determining current impairment or recent dosing. Because d-amphetamine’s plasma half-life is around 10 hours, blood levels drop below detectable thresholds faster than urine concentrations do. For most people, d-amphetamine is undetectable in blood within about 24 to 36 hours of the last dose, though this varies with individual metabolism.

Urine pH Matters More Than You’d Expect

One of the biggest variables in how quickly you clear amphetamine is something most people never think about: the acidity of your urine. Amphetamine excretion through the kidneys is highly pH-dependent. When urine is acidic, more than 70 percent of amphetamine is excreted unchanged. When urine is alkaline, less than 5 percent leaves the body that way.

⁵

That is a dramatic swing. If your urine happens to be more alkaline on a given day, from diet, hydration, antacids, or certain medications, your body reabsorbs much more of the amphetamine back from the kidneys into the bloodstream rather than flushing it out. The drug sticks around longer, effects last longer, and a drug test stays positive longer. Conversely, acidic urine speeds elimination considerably. This is not a theoretical footnote; it is the single largest source of person-to-person variability in amphetamine clearance. Your friend who takes the same dose might clear it noticeably faster or slower than you do based partly on what they ate and drank that day.

Kidney Function and Other Individual Factors

Because the kidneys are the primary exit route for d-amphetamine, anything that impairs kidney function slows elimination. A study that compared lisdexamfetamine pharmacokinetics across groups ranging from normal kidney function to end-stage renal disease found that total drug exposure increased and clearance decreased as kidney impairment worsened. People with end-stage renal disease had roughly a 50 percent reduction in total body clearance compared to those with healthy kidneys, and their half-life was the longest of any group.

⁵

Beyond kidney health, several other factors influence how long d-amphetamine lingers:

Body weight and composition: Amphetamine is distributed throughout lean body mass, so larger individuals may have a somewhat longer elimination curve.
Age: Older adults tend to have reduced renal clearance even without overt kidney disease, which can extend detection windows modestly.
Hydration: Higher fluid intake increases urine output and can dilute drug concentration in any given sample, though it doesn’t dramatically speed the actual elimination of the drug from your body.
Dose and duration of use: Someone who has been taking 70 mg daily for months has accumulated more d-amphetamine in their system than someone who took a single 30 mg dose. Steady-state accumulation means the drug takes longer to fully clear after the last dose.

None of these factors will move your detection window by days the way urine pH can, but they all nudge it in one direction or another.

Drug Tests, False Positives, and Confirmatory Testing

If you take Vyvanse with a valid prescription and face a drug test, the standard immunoassay screen will flag your sample as positive for amphetamines. That is not a false positive; it is a true positive for a legally prescribed medication. The process from there is straightforward: you disclose your prescription, the lab runs a confirmatory test if needed, and the result is reported as consistent with prescribed use.

Where things get more interesting is the confirmatory step. Standard immunoassay screens are designed to cast a wide net. They react to a family of structurally similar compounds, not just d-amphetamine. This means a number of other medications can trigger a positive result on the initial screen even in someone who has never taken any amphetamine. Prescription drugs like certain antidepressants, antihistamines, antipsychotics, and even over-the-counter nasal decongestants containing pseudoephedrine have been reported to cause false-positive amphetamine results on immunoassay.

⁶

Confirmatory testing resolves this ambiguity. Laboratories use techniques like liquid chromatography-tandem mass spectrometry (LC-MS/MS), which can identify the exact compound present in the sample and even distinguish between optical isomers of amphetamine.

⁷ Vyvanse produces only d-amphetamine (the dextro- form), so confirmatory testing of someone on Vyvanse will show d-amphetamine specifically.

⁸ The presence of l-amphetamine (the levo- form) alongside d-amphetamine would suggest a different source, such as Adderall, which contains a mix of both isomers, or illicit methamphetamine, which metabolizes into both forms. This chiral separation is a powerful forensic tool that can distinguish between different amphetamine sources with high confidence.

How Vyvanse Compares to Other Stimulant Formulations

People often wonder whether Vyvanse stays in the system longer or shorter than Adderall or other amphetamine medications. The answer is nuanced. Once Vyvanse is converted to d-amphetamine, the elimination half-life of that d-amphetamine is the same as if you had taken d-amphetamine directly. A head-to-head pharmacokinetic study confirmed that when lisdexamfetamine and d-amphetamine were given at equivalent doses, total drug exposure was essentially identical between the two.

⁹

The difference is in the front end, not the back end. Vyvanse takes longer to reach peak blood levels because of the conversion step. Plasma amphetamine concentrations rose about an hour later after lisdexamfetamine compared with direct d-amphetamine.

⁹ That delayed onset is part of the design: a slower ramp-up is thought to reduce abuse potential and provide a smoother clinical effect throughout the day. But once the d-amphetamine is circulating, it clears at the same rate regardless of whether it came from Vyvanse, Dexedrine, or the d-amphetamine component of Adderall.

For drug testing purposes, this means Vyvanse and other d-amphetamine medications produce nearly identical detection windows when taken at equivalent doses. The prodrug design does not help the drug leave your system any faster.

Food, Stomach Acid Medications, and Absorption

A common question is whether eating food or taking antacids before Vyvanse affects how long it stays in your system. Because Vyvanse is a prodrug that relies on enzymatic conversion in red blood cells rather than on gut-level dissolution, its pharmacokinetics are less sensitive to gastrointestinal conditions than many other oral medications.

A study tested whether the proton pump inhibitor omeprazole, which raises stomach pH substantially, would alter lisdexamfetamine absorption. It found no meaningful change in peak concentration or total exposure to d-amphetamine when Vyvanse was taken with omeprazole. The median time to peak levels stayed at three hours either way.

¹⁰ By contrast, the same study found that omeprazole did shift the absorption profile of extended-release mixed amphetamine salts (Adderall XR), with more than half of subjects reaching peak levels at least an hour earlier when taking the antacid. This difference exists because Adderall XR relies on a pH-dependent coating to control release in the gut, while Vyvanse does not.

Eating a high-fat meal with an extended-release amphetamine formulation has been shown to delay the time to peak concentration by several hours without changing the total amount of drug absorbed.

¹¹ A similar delay occurs with Vyvanse, though the effect tends to be smaller. Either way, while food can shift when peak effects hit, it does not meaningfully change how much drug your body ultimately absorbs or how long it takes to fully clear.

The Prodrug Conversion Step

The specific mechanism behind Vyvanse’s activation is worth understanding because it explains several features of the drug that matter practically. Lisdexamfetamine is d-amphetamine bonded to the amino acid lysine. That bond must be broken before the drug works. Research has established that this hydrolysis happens inside red blood cells, specifically in the cytosol, and that the responsible enzyme is an aminopeptidase.

¹²

This is unusual. Most prodrugs are activated in the liver or gut. The fact that Vyvanse relies on red blood cells means the conversion happens gradually as the drug circulates through the bloodstream, which creates a natural rate limit. You cannot speed up the conversion by taking more at once, snorting it, or injecting it, because the bottleneck is the finite capacity of your red blood cells to cleave the lysine bond. This rate-limiting property is the core reason Vyvanse was designed as a prodrug in the first place: it resists dose-dumping and makes the drug harder to abuse compared with immediate-release amphetamine formulations.

From an elimination standpoint, the red blood cell conversion also means that intact lisdexamfetamine and d-amphetamine coexist in your blood for a brief window after each dose. The intact prodrug is cleared so quickly (half-life under an hour) that it contributes almost nothing to your overall drug exposure. The entire pharmacological story, both therapeutic effects and detection on drug tests, is really about the d-amphetamine that emerges from that conversion.

Practical Advice If You Face a Drug Test

If you take Vyvanse as prescribed and need to take a drug test for employment, legal, or medical reasons, the most reliable step is to disclose your prescription to the medical review officer (MRO) who interprets the results. In regulated workplace testing programs in the United States, the MRO is trained to verify prescriptions and will report a positive amphetamine result as consistent with prescribed use. Failing to disclose can create unnecessary complications even when your use is completely legal.

Bring documentation: a copy of your prescription, a pharmacy printout, or a letter from your prescribing physician. Most testing programs have a clear process for handling prescribed stimulants, and you will not face adverse consequences for a legitimate prescription as long as you can verify it.

If you have recently stopped taking Vyvanse and want to know whether it has fully cleared, the rough math based on the half-life and detection data suggests waiting at least three to four days after your last dose for urine to test negative, though individual variation means this is not guaranteed. People with impaired kidney function, those who were taking high doses for a long time, or those whose urine pH tends to run alkaline may need to wait longer. Hair testing, of course, operates on an entirely different timeline and will reflect use from the past several months regardless of when you stopped.